Tacrolimus Capsule, Coated, Extended Release
Product Images NDC 71432-2002

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Tacrolimus (NDC 71432-2002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Chengdu Suncadia Medicine Co., Ltd., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Tacrolimus 01)

FDA Label Image

Figure 1 (Tacrolimus 02)

FDA Label Image

Figure 2 (Tacrolimus 03)

This is a list of pharmacokinetic parameters and a comparison of co-administered drugs with tacrolimus in immediate release form. The text discusses various drugs and their impact on tacrolimus levels in the body. The geometric mean ratio of test to reference and confidence intervals are provided for reference. Immediate-release tacrolimus was given as a single dose in all studies.*

FDA Label Image

0.5 (Tacrolimus 04)

This is a detailed product label for Tacrolimus Extended-Release Capsules manufactured by Chengdu Suncadia Medicine Co. in China. The capsules contain 0.5 mg of Tacrolimus and need to be taken once daily, with each capsule also listing its inactive ingredients. The product is distributed by eVenus Pharmaceutical Laboratories Inc. in Princeton, USA, and comes in a package containing 50 capsules. The label provides storage instructions, dosage information, and notes about the capsule capacity. Additionally, it includes details about the capsule size (1mm x 26mm) and the necessary overcoding information.*

FDA Label Image

1 (Tacrolimus 05)

This is a product information sheet detailing Tacrolimus Extended-Release Capsules, manufactured in China and distributed in the USA. Each capsule contains 1 mg of Tacrolimus along with inactive ingredients. The capsules are intended for once-daily use and are packaged with a medication guide. The storage instructions are provided, and it is noted that the capsules are not filled to maximum capacity. Additional dosage information can be found in the package insert. The product is available in a pack containing 50 capsules.*

FDA Label Image

5 (Tacrolimus 06)

This text provides details about Tacrolimus Extended-Release Capsules, a medication that is intended for once-daily use. It contains 50 capsules divided into 5 blister cards, each card containing 10 capsules. The enclosed Medication Guide is to be dispensed to each patient.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.